APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 1 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,316,184 | +211.2% | 34,600 | +458.7% | 0.01% | +180.0% |
| Q3 2022 | $423,000 | +54.4% | 6,193 | +2.2% | 0.01% | +66.7% |
| Q2 2022 | $274,000 | -65.3% | 6,060 | -61.0% | 0.00% | -57.1% |
| Q1 2022 | $790,000 | -86.5% | 15,549 | -87.4% | 0.01% | -84.8% |
| Q4 2021 | $5,839,000 | -35.8% | 123,490 | -55.2% | 0.05% | -35.2% |
| Q3 2021 | $9,094,000 | -18.9% | 275,910 | +55.4% | 0.07% | -13.4% |
| Q2 2021 | $11,220,000 | – | 177,525 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 1,526,122 | $29,759,000 | 24.10% |
| Cormorant Asset Management, LP | 3,600,000 | $70,200,000 | 4.74% |
| SECTORAL ASSET MANAGEMENT INC | 1,727,829 | $33,693,000 | 4.05% |
| Hillhouse Capital Management | 2,098,581 | $40,922,000 | 1.71% |
| HHLR ADVISORS, LTD. | 2,579,708 | $50,304,000 | 1.40% |
| CLOUGH CAPITAL PARTNERS L P | 589,734 | $11,500,000 | 1.01% |
| Vivo Capital, LLC | 383,538 | $7,479,000 | 0.75% |
| Opaleye Management Inc. | 115,000 | $2,243,000 | 0.62% |
| Virtus ETF Advisers LLC | 14,338 | $280,000 | 0.60% |
| Eversept Partners, LP | 104,349 | $2,034,806 | 0.59% |